The global Polyglucose and Sodium Chloride Injection market size is predicted to grow from US$ 28.8 million in 2025 to US$ 40.7 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031.

Polyglucose and Sodium Chloride Injection is an aqueous solution containing glucose and sodium chloride, which is mainly used to replenish water, electrolytes and energy in the body. It combines the immediate energy source provided by glucose with the role of sodium chloride in maintaining body fluid osmotic pressure and electrolyte balance. It is suitable for adjuvant treatment of patients with dehydration, hypoglycemia or electrolyte disorders caused by various reasons, such as postoperative, severe vomiting and diarrhea, malnutrition, etc. The injection is given by intravenous infusion and can be quickly absorbed and utilized by the body to help restore physiological functions and stabilize the internal environment.

United States market for Polyglucose and Sodium Chloride Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Polyglucose and Sodium Chloride Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Polyglucose and Sodium Chloride Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Polyglucose and Sodium Chloride Injection players cover Peking University Pharmaceutical Co., Ltd., Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd., Chongqing Dikang Changjiang Pharmaceutical Co., Ltd., Zhejiang Guojing Pharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

Infinity Market Research newest research report, the ?Polyglucose and Sodium Chloride Injection Industry Forecast? looks at past sales and reviews total world Polyglucose and Sodium Chloride Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Polyglucose and Sodium Chloride Injection sales for 2025 through 2031. With Polyglucose and Sodium Chloride Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Polyglucose and Sodium Chloride Injection industry.

This Insight Report provides a comprehensive analysis of the global Polyglucose and Sodium Chloride Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Polyglucose and Sodium Chloride Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Polyglucose and Sodium Chloride Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Polyglucose and Sodium Chloride Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Polyglucose and Sodium Chloride Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Polyglucose and Sodium Chloride Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    500ml: 60g Condensed Glucose and 4.25g Sodium Chloride
    250ml: 30g Condensed Glucose and 2.125g Sodium Chloride

Segmentation by Application:

    Hospital
    Clinic
    Other

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Peking University Pharmaceutical Co., Ltd.
    Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd.
    Chongqing Dikang Changjiang Pharmaceutical Co., Ltd.
    Zhejiang Guojing Pharmaceutical Co., Ltd.
    Sichuan Kelun Pharmaceutical Co., Ltd.
    Shijiazhuang Siyao Co., Ltd.
    Huiyinbi Group Jiangxi East Asia Pharmaceutical Co., Ltd.
    Yichang Three Gorges Pharmaceutical Co., Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Polyglucose and Sodium Chloride Injection market?
What factors are driving Polyglucose and Sodium Chloride Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Polyglucose and Sodium Chloride Injection market opportunities vary by end market size?
How does Polyglucose and Sodium Chloride Injection break out by Type, by Application?